125 related articles for article (PubMed ID: 24399627)
1. [Description of a case of hyperkinetic movement disorder in neonatal onset multisystem inflammatory disease or chronic infantile neurologic cutaneous and articular syndrome].
Gómez-Camello Á; Ortego-Centeno N
Rev Neurol; 2014 Jan; 58(2):94-6. PubMed ID: 24399627
[TBL] [Abstract][Full Text] [Related]
2. Chorea in a patient with cryopyrin-associated periodic syndrome.
Schwarzbach CJ; Schmitt WH; Szabo K; Bäzner H; Hennerici MG; Blahak C
Neurology; 2016 Jan; 86(3):241-4. PubMed ID: 26683645
[TBL] [Abstract][Full Text] [Related]
3. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
[TBL] [Abstract][Full Text] [Related]
4. Neurologic manifestations of the cryopyrin-associated periodic syndrome.
Kitley JL; Lachmann HJ; Pinto A; Ginsberg L
Neurology; 2010 Apr; 74(16):1267-70. PubMed ID: 20404307
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
Sarrabay G; Grandemange S; Touitou I
Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neopterin and cryopyrin-associated periodic syndrome.
Serrano M; Ormazábal A; Antón J; Aróstegui JI; García-Cazorla A
Pediatr Neurol; 2009 Dec; 41(6):448-50. PubMed ID: 19931168
[TBL] [Abstract][Full Text] [Related]
7. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
Wohlrab F; Bauknecht C; Meisel C; Dreier JP
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):e1-3. PubMed ID: 33109682
[No Abstract] [Full Text] [Related]
8. Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
Ting TV; Scalzi LV; Hashkes PJ
Pediatr Neurol; 2007 May; 36(5):338-41. PubMed ID: 17509468
[TBL] [Abstract][Full Text] [Related]
9. Cryopyrin-associated periodic syndrome: a case report and review of the Japanese literature.
Aoyama K; Amano H; Takaoka Y; Nishikomori R; Ishikawa O
Acta Derm Venereol; 2012 Jul; 92(4):395-8. PubMed ID: 22377911
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-genotype analysis of cryopyrin-associated periodic syndromes (CAPS): description of a rare non-exon 3 and a novel CIAS1 missense mutation.
Jesus AA; Silva CA; Segundo GR; Aksentijevich I; Fujihira E; Watanabe M; Carneiro-Sampaio M; Duarte AJ; Oliveira JB
J Clin Immunol; 2008 Mar; 28(2):134-8. PubMed ID: 18080732
[TBL] [Abstract][Full Text] [Related]
11. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
12. Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes.
Cantarini L; Lucherini OM; Frediani B; Brizi MG; Bartolomei B; Cimaz R; Galeazzi M; Rigante D
Int J Immunopathol Pharmacol; 2011; 24(4):827-36. PubMed ID: 22230390
[TBL] [Abstract][Full Text] [Related]
13. Neonatal treatment of CINCA syndrome.
Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
[TBL] [Abstract][Full Text] [Related]
14. Renal and thyroid amyloidosis secondary tocryopyrin-associated periodic syndrome(Muckle-Wells syndrome) (NLRP3 mutation).
Bolaños L; Mosquera-Reboredo JM; Cao M; Ferreiro T; Veleiro B; Valdés F; Vázquez-Martul E
Nefrologia; 2013; 33(2):266-71. PubMed ID: 23511763
[No Abstract] [Full Text] [Related]
15. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
[No Abstract] [Full Text] [Related]
16. Early-onset urticaria: a marker of cryopyrin-associated periodic syndrome.
Sathishkumar D; Al-Abadi E; Nicklaus-Wollenteit I; Moss C; Hawkins PN; Gach JE
Clin Exp Dermatol; 2017 Jul; 42(5):579-581. PubMed ID: 28512856
[No Abstract] [Full Text] [Related]
17. Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation.
Alejandre N; Ruiz-Palacios A; García-Aparicio AM; Blanco-Kelly F; Bermúdez S; Fernández-Sanz G; Romero FI; Aróstegui JI; Ayuso C; Jiménez-Alfaro I; Herrero-Beaumont G; Sánchez-Pernaute O
Rheumatology (Oxford); 2014 Jun; 53(6):1095-9. PubMed ID: 24501247
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry.
Levy R; Gérard L; Kuemmerle-Deschner J; Lachmann HJ; Koné-Paut I; Cantarini L; Woo P; Naselli A; Bader-Meunier B; Insalaco A; Al-Mayouf SM; Ozen S; Hofer M; Frenkel J; Modesto C; Nikishina I; Schwarz T; Martino S; Meini A; Quartier P; Martini A; Ruperto N; Neven B; Gattorno M;
Ann Rheum Dis; 2015 Nov; 74(11):2043-9. PubMed ID: 25038238
[TBL] [Abstract][Full Text] [Related]
19. Dopamine depleters in the treatment of hyperkinetic movement disorders.
Jankovic J
Expert Opin Pharmacother; 2016 Dec; 17(18):2461-2470. PubMed ID: 27819145
[TBL] [Abstract][Full Text] [Related]
20. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
Idorn L; Vissing NH; Jensen L; Herlin T
Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
